Large inefficiency from 250 to about 300. Series of higher lowz despite ugly earnings and outlook. Think of it this way: In march and height of pandemic the worst was probably priced in. IMO more meat on the bone in terms of upside. Its a patient setup but upside is there.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.